Related Experiment Video

Updated: May 15, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Targeting the mTOR pathway in tumor malignancy

Hengmiao Cheng1, Marlena Walls, Sangita M Baxi

  • 1Pfizer Worldwide Research and Development, 10724 Science Center Drive, San Diego, CA 92121, USA.

Current Cancer Drug Targets
|January 10, 2013
PubMed

Insights

The mammalian target of rapamycin (mTOR) pathway regulates cell growth and metabolism. Dysregulation of mTOR signaling is implicated in cancer, suggesting mTOR inhibitors as a potential therapeutic strategy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The mammalian target of rapamycin (mTOR) is a key regulator of cell growth, proliferation, and metabolism.
  • mTOR functions within two distinct complexes, mTORC1 and mTORC2, each with unique roles.
  • mTORC1 controls temporal aspects of cell growth, while mTORC2 influences spatial organization.

Purpose of the Study:

  • To elucidate the mechanisms by which mTOR signaling contributes to tumor malignancy.
  • To explore the therapeutic potential of mTOR inhibitors in cancer treatment.

Main Methods:

  • Review of signaling pathways regulating mTOR in cancer.
  • Analysis of mTOR complex functions in cellular processes.
  • Discussion of mTOR inhibitor efficacy.

Main Results:

  • mTOR signaling is intricately linked to various pathways driving tumor progression.
  • mTORC1 and mTORC2 complexes play distinct roles in cancer cell biology.
  • mTOR inhibitors show promise as anti-cancer agents.

Conclusions:

  • Understanding mTOR regulation in malignancy is crucial for developing targeted therapies.
  • Targeting the mTOR pathway offers a viable strategy for cancer treatment.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...